Big Pharma är inte att lita på eller deras medlöpare! Mediciner som godkänts av amerikanska myndigheter före 2025 skall man vara skeptisk emot.

•In early 2023, a private conference with pharmaceutical industry leaders and investors highlighted anti-obesity and Alzheimer’s drugs as the next big money-makers and had the FDA head as its keynote speaker.

•Since then, the FDA has taken questionable steps to promote these drugs, particularly Ozempic, an anti-obesity medication. There’s been a massive push to get everyone, including children, on Ozempic, using shockingly aggressive marketing tactics.

•This rush is eerily similar to the fen-phen craze, a temporary weight loss drug later pulled from the market for causing severe heart and lung issues.

•Worse, Ozempic comes with serious side effects, including paralyzing the digestive tract. This article will address the above controversy and explore the common causes of obesity, including those rarely discussed.

Läs vidare den viktiga (men långa) texten på The Forgotten Side of Medicine.